Edgestream Partners L.P. Invests $6.38 Million in DaVita Inc. $DVA

Edgestream Partners L.P. purchased a new stake in shares of DaVita Inc. (NYSE:DVA) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 44,754 shares of the company’s stock, valued at approximately $6,375,000. Edgestream Partners L.P. owned approximately 0.06% of DaVita at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Dynamic Technology Lab Private Ltd bought a new stake in shares of DaVita in the first quarter worth approximately $364,000. LPL Financial LLC boosted its holdings in DaVita by 36.2% in the first quarter. LPL Financial LLC now owns 18,689 shares of the company’s stock worth $2,859,000 after purchasing an additional 4,968 shares during the last quarter. Caxton Associates LLP bought a new stake in DaVita in the 1st quarter worth approximately $513,000. Sovran Advisors LLC purchased a new stake in DaVita during the 2nd quarter valued at $472,000. Finally, Strs Ohio bought a new position in shares of DaVita during the 1st quarter valued at $1,429,000. 90.12% of the stock is currently owned by institutional investors.

DaVita Trading Down 0.1%

DaVita stock opened at $119.08 on Wednesday. DaVita Inc. has a 12-month low of $113.97 and a 12-month high of $179.60. The firm has a market capitalization of $8.41 billion, a price-to-earnings ratio of 12.26, a P/E/G ratio of 0.90 and a beta of 1.00. The firm has a 50 day moving average of $124.51 and a 200 day moving average of $133.29.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $2.51 earnings per share for the quarter, missing analysts’ consensus estimates of $3.17 by ($0.66). The firm had revenue of $3.42 billion during the quarter, compared to the consensus estimate of $3.43 billion. DaVita had a negative return on equity of 13,370.89% and a net margin of 5.80%.The business’s revenue for the quarter was up 4.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.59 earnings per share. DaVita has set its FY 2025 guidance at 10.350-11.150 EPS. On average, analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of DaVita in a report on Monday. Cowen restated a “hold” rating on shares of DaVita in a research note on Monday, November 3rd. Bank of America reduced their price target on shares of DaVita from $145.00 to $140.00 and set an “underperform” rating for the company in a research report on Wednesday, September 10th. Barclays dropped their price objective on shares of DaVita from $149.00 to $143.00 and set an “equal weight” rating on the stock in a report on Thursday, October 30th. Finally, TD Cowen reduced their target price on shares of DaVita from $154.00 to $133.00 and set a “hold” rating for the company in a report on Monday, November 3rd. Six equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, DaVita currently has a consensus rating of “Reduce” and a consensus price target of $148.00.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.